Background: Labetalol remains the drug of choice for blood pressure control in patients with severe pre-eclampsia. Two methods of iv administration of labetalol are possible in the intrapartum period. Bolus intermittent labetalol injection commonly has the problem of reaching the maximum daily dose of 300mg within a short time (usually in one to two hours) often without achieving the desired blood pressure. Continuous intravenous labetalol infusion on the other hand can effectively be used for up to 10hrs. Very few studies have tried to compare the efficacy of both methods as well as comparing maternal and neonatal outcomes. Aim: This study aims to compare the efficacy of bolus intermittent labetalol injections and the continuous labetalol infusion after an initial loading dose for the intrapartum management of severe preeclampsia. Methodology: This study was carried out among severe pre eclamptic patients in the intrapartum period managed at Irrua Specialist Teaching Hospital to compare the time to achieve effective blood pressure control between intermittent bolus injections and continuous labetalol. The study also compared adverse maternal or fetal outcome.